Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
04/2007
04/05/2007CA2623374A1 Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
04/05/2007CA2623034A1 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
04/05/2007CA2622701A1 Amino-aza-adamantane derivatives and methods of use
04/04/2007EP1770129A2 Modified carbocyanine dyes and their conjugates
04/04/2007EP1770093A1 Pyrido¬2,3-d|pyrimidine derivatives as phosphodiesterase inhibitors
04/04/2007EP1769048A1 Fluorescent quinacridones
04/04/2007EP1768985A1 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
04/04/2007EP1768983A2 Fused heterocyclic kinase inhibitors
04/04/2007EP1768981A1 Novel pyridodihydropyrazinones method for production and use thereof as medicaments
04/04/2007EP1768980A2 Improved process for the manufacture of mirtazapine
04/04/2007EP1768979A1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof
04/04/2007EP1768957A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
04/04/2007EP1768667A1 Cannabinoid receptor ligands
04/04/2007EP1377556B1 Pyrazole derivatives for treating hiv
04/04/2007EP1219609B1 Aromatic nitrogenous six-membered ring compounds
04/04/2007CN1942471A Substituted diaza-spiro-[5.5|-undecane derivatives and their use as neurokinin antagonists
04/04/2007CN1942470A Akt活性抑制剂 Akt activity inhibitor
04/04/2007CN1942469A Condensed pyridine derivatives useful as A28 adenosine receptor antagonists
04/04/2007CN1942468A Process for production of pyrazole-fused ring derivatives
04/04/2007CN1942191A Pharmaceutical composition comprising a salt of mirtazapine
04/04/2007CN1939918A Production of midanping
04/04/2007CN1939307A 2,4,6-triamino-1,3,5-triazine derivative
04/04/2007CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
04/04/2007CN1308327C Imidazopyridine derivatives
04/04/2007CN1308313C Fused azepine drivatives and their use as antidiuretic agents
04/04/2007CN1308310C Nitrogenous aromatic ring compounds
04/03/2007US7199242 Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof
04/03/2007US7199131 Administration of N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide to induce interferon-alpha biosynthesis or as a viricide or anticarcinogenic agent
04/03/2007US7199120 Pyrazolo-pyridine derivatives as antiherpes agents
04/03/2007US7199119 Antiinflammation agents
04/03/2007US7199117 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, and learning and memory disorders; 2-[4-[4-Pyrrolidinobut-1-ynyl]phenyl]-7-methylimidazo[1,2-a]pyridine for example
04/03/2007CA2236269C Selective .beta.3 adrenergic agonists
04/03/2007CA2180660C Novel piperidine derivatives with paf antagonist activity
03/2007
03/29/2007WO2007035935A1 METHOD FOR 1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF
03/29/2007WO2007035703A1 1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist
03/29/2007WO2007035428A1 Met kinase inhibitors
03/29/2007WO2007035003A1 Process for producing optically active piperazine compound
03/29/2007WO2007034278A2 Fused imidazole derivatives as c3a receptor antagonists
03/29/2007WO2007034277A1 Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007WO2007019126A3 Method of preparation of azaindole derivatives
03/29/2007WO2007015809A3 Hiv reverse transcriptase inhibitors
03/29/2007WO2007011833A3 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/29/2007WO2006128143A3 Hydantoin compounds
03/29/2007WO2006126177A3 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
03/29/2007WO2006124731A3 Compounds and compositions as protein kinase inhibitors
03/29/2007WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists
03/29/2007WO2006116185A3 Methods for the treatment of multiple myeloma
03/29/2007WO2006108965A3 Npy antagonists, preparation and use
03/29/2007WO2005110410A3 Kinase inhibitors as therapeutic agents
03/29/2007WO2005092066A8 Imidazole compounds
03/29/2007US20070072898 MAP KAP-K2 inhibitory activity; for treating inflammatory injury, autoimmune diseases, asteropathia destruens, cancer and/or growth of tumors
03/29/2007US20070072897 1-[5-(benzyloxy)-1H-indol-1-yl]-3-(methylamino)-1-phenylpropan-2-ol;fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence
03/29/2007US20070072896 Inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders relating to apoptosis and/or inflammation
03/29/2007US20070072895 Polymorphs of 1-cyclopropyl-7-([s,s])-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro -8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
03/29/2007US20070072894 Synthesis of pyrroloquinoline quinone (PQQ)
03/29/2007US20070072893 Substituted imidazo ring systems and methods
03/29/2007US20070072866 that inhibit the metabolic activity of the enzyme glycogen synthase kinase 3 beta (GSK-3 beta), which is believed to cause the neurodegeneration that results in diseases of the central nervous system; enzyme inhibitors
03/29/2007US20070072863 thieno [2,3-b: 5,4-c'] dipyridine derivatives, used as as selective metabotropic glutamate receptor 1 (mGluR1) antagonists, for the treatment of pain, headaches, anxiety, incontinence and neurodegenerative diseases such as Alzheimer's disease
03/29/2007US20070072851 Pyrazolopyridine and pyrazolopyrimidine compounds
03/29/2007US20070072844 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/29/2007US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
03/29/2007US20070072831 Integrase inhibitor compounds
03/29/2007US20070072792 Macrocyclic lactams and pharmaceutical use thereof
03/29/2007DE10116303B4 Vefahren zur Herstellung N-überbrückter Heterobicyclen Vefahren for preparing N-bridged heterobicycles
03/29/2007CA2623541A1 Method for 1h-imidazo[4,5-c]pyridines and analogs thereof
03/29/2007CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007CA2623025A1 1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist
03/29/2007CA2621720A1 Carbazole derivatives
03/28/2007EP1767536A1 Quinolone carboxylic acid derivatives, thereof preparation and usage
03/28/2007EP1765829A1 Tricyclic compounds and their use as mglur1 antagonists
03/28/2007EP1765825A1 Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases
03/28/2007EP1765819A1 Azaindoles useful as inhibitors of protein kinases
03/28/2007EP1765818A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use
03/28/2007EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/28/2007EP1765777A2 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors
03/28/2007EP1765348A2 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
03/28/2007EP1575956B1 Fungicides based on nitrogen-containing heterocycles
03/28/2007EP1497294B1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS
03/28/2007EP1453836B1 BICYCLIC [1,2,4] -TRIAZOLE ADENOSINE A2a RECEPTOR ANTAGONISTS
03/28/2007EP1228071B1 Pharmaceutically active isoindoline derivatives
03/28/2007EP1138745B1 Organic electroluminescent element
03/28/2007CN1938320A Compounds and methods for treating dyslipidemia
03/28/2007CN1938315A Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same
03/28/2007CN1938306A Crystalline forms of 5, 11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one
03/28/2007CN1938305A 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof
03/28/2007CN1938304A Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
03/28/2007CN1938303A Azaindoles useful as inhibitors of jak and other protein kinases
03/28/2007CN1938302A 激酶抑制剂 Kinase inhibitors
03/28/2007CN1938301A Tetrahydronaphthyridine derivatives as cholesteryl ester transfer protein inhibitors
03/28/2007CN1938273A Tetrahydrocarbazoles and derivatives
03/28/2007CN1935809A Oxysophocarpine and its salt preparing method
03/28/2007CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog
03/28/2007CN1307178C Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists
03/28/2007CN1307176C Novel alkoxypyridine-derivatives
03/28/2007CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands
03/28/2007CN1307174C Imidazoquinoline derivatives
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
03/27/2007US7196200 5-oxo-5,8-dihydro[2,3-d]pyrimidinopyridine-6-carboxylic acids or 7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acids; fish or mammals; bacterial protein biosynthesis inhibitors
03/27/2007US7196196 Substituted imidazo[1, 2-a]-5,6,7,8-tetrahydropyridine-8-ones, method for their production and the use thereof for producing imidazo[1,2-a]pyridines